The Column Group logo

The Column Group

North America, California, United States, San Francisco

Description

The Column Group is a venture capital firm dedicated to developing biotechnology companies.

Investor Profile

The Column Group has made 124 investments, with 9 in the past 12 months and 37% as lead.

Stage Focus

  • Series A (31%)
  • Series B (26%)
  • Series C (16%)
  • Series D (7%)
  • Series Unknown (7%)
  • Post Ipo Equity (6%)
  • Series E (4%)
  • Seed (2%)
  • Private Equity (1%)
  • Series F (1%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Genetics
  • Medical Device
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Column Group frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 13
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 14
EC
North America, New York, United States, New York
Co-Investments: 17
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 15
Third Rock Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 18
Casdin Capital
North America, New York, United States, New York
Co-Investments: 13
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 13
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 14
Lux Capital
North America, New York, United States, New York
Co-Investments: 13
Topspin Partners
North America, New York, United States, Mamaroneck
Co-Investments: 11

Which angels does The Column Group often collaborate with?

JT
North America, California, United States, San Francisco
Shared Deals: 1
ZH
North America, California, United States, Berkeley
Shared Deals: 1
BG
North America, Washington, United States, Seattle
Shared Deals: 3
Shared Deals: 1
AD
North America, California, United States, San Francisco
Shared Deals: 1
AE
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by The Column Group?

Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
Surrozen

South San Francisco, California, United States

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

BiotechnologyEmergency MedicineHealth Care
Post Ipo EquityMar 24, 2025
Amount Raised: $175,000,000
Eikon Therapeutics

Hayward, California, United States

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

BiotechnologyHealth CareLife ScienceMedical
Series DFeb 26, 2025
Amount Raised: $350,700,000
A2 Biotherapeutics

Agoura Hills, California, United States

A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.

BiotechnologyHealth CareLife Science
Series CJan 9, 2025
Amount Raised: $80,000,000
Rapt Therapeutics

South San Francisco, California, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityDec 23, 2024
Amount Raised: $150,000,000
Nura Bio

South San Francisco, California, United States

Nura Bio is a clinical-stage biopharmaceutical company focused on developing neuroprotective therapies to treat neurological diseases.

BiotechnologyHealth CareMedicalWellness
Series ASep 17, 2024
Amount Raised: $68,000,000
Circle Pharma

San Francisco, California, United States

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

BiotechnologyClinical TrialsHealth CareTherapeutics
Series DSep 3, 2024
Amount Raised: $90,000,000
NGM Biopharmaceuticals

South San Francisco, California, United States

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

BiopharmaBiotechnologyGeneticsMedical
Series AJul 17, 2024
Amount Raised: $122,000,000
Circle Pharma

San Francisco, California, United States

Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.

BiotechnologyClinical TrialsHealth CareTherapeutics
Series DJul 2, 2024
Amount Raised: $54,171,999
InduPro

Seattle, Washington, United States

InduPro is a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies.

BiotechnologyMedicalTherapeutics
Series AJun 13, 2024
Amount Raised: $85,000,000